Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA

Watchlist Manager
Sun Pharmaceutical Industries Ltd Logo
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Watchlist
Price: 1 814.6 INR 0.32% Market Closed
Market Cap: 4.4T INR
Have any thoughts about
Sun Pharmaceutical Industries Ltd?
Write Note

Wall Street
Price Targets

SUNPHARMA Price Targets Summary
Sun Pharmaceutical Industries Ltd

Wall Street analysts forecast SUNPHARMA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SUNPHARMA is 2 031.9 INR with a low forecast of 1 344.31 INR and a high forecast of 2 572.5 INR.

Lowest
Price Target
1 344.31 INR
26% Downside
Average
Price Target
2 031.9 INR
12% Upside
Highest
Price Target
2 572.5 INR
42% Upside
Sun Pharmaceutical Industries Ltd Competitors:
Price Targets
4577
Daito Pharmaceutical Co Ltd
40% Upside
600436
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
29% Upside
214370
Caregen Co Ltd
48% Downside
JUBLPHARMA
Jubilant Pharmova Ltd
28% Upside
ROVI
Laboratorios Farmaceuticos ROVI SA
52% Upside
600195
China Animal Husbandry Industry Co Ltd
13% Upside
688513
Chengdu Easton Biopharmaceuticals Co Ltd
42% Upside
SUPRIYA
Supriya Lifescience Ltd
18% Downside

Revenue
Forecast

Revenue Estimate
Sun Pharmaceutical Industries Ltd

For the last 8 years the compound annual growth rate for Sun Pharmaceutical Industries Ltd's revenue is 7%. The projected CAGR for the next 3 years is 10%.

7%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Sun Pharmaceutical Industries Ltd

For the last 8 years the compound annual growth rate for Sun Pharmaceutical Industries Ltd's operating income is 4%. The projected CAGR for the next 3 years is 15%.

4%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Sun Pharmaceutical Industries Ltd

For the last 8 years the compound annual growth rate for Sun Pharmaceutical Industries Ltd's net income is 10%. The projected CAGR for the next 3 years is 16%.

10%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-15%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SUNPHARMA's stock price target?
Price Target
2 031.9 INR

According to Wall Street analysts, the average 1-year price target for SUNPHARMA is 2 031.9 INR with a low forecast of 1 344.31 INR and a high forecast of 2 572.5 INR.

What is Sun Pharmaceutical Industries Ltd's Revenue forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Sun Pharmaceutical Industries Ltd's revenue is 7%. The projected CAGR for the next 3 years is 10%.

What is Sun Pharmaceutical Industries Ltd's Operating Income forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for Sun Pharmaceutical Industries Ltd's operating income is 4%. The projected CAGR for the next 3 years is 15%.

What is Sun Pharmaceutical Industries Ltd's Net Income forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Sun Pharmaceutical Industries Ltd's net income is 10%. The projected CAGR for the next 3 years is 16%.

Back to Top